IFNG and cancer: By releasing IFNγ and cytolytic granules, γδ T cells can kill myeloma cells, recognized through ICAM-1 and mevalonate pathway metabolites on the surface [32], while the majority of melanoma-infiltrating γδ T cells is able to kill cancer cells by producing IFNγ and TNF-α [33].